Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Winning the CKD-aP Battle: A United Physician-Nurse Front
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Gabapentinoids: Safety Considerations and Downstream Outcomes
Spotlight on Assessment: Tools That Capture CKD-aP
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
What You Don’t See: A Patient’s View of Living with CKD-aP
ASCVD Playbook | Closing the Gaps, One Inning at a Time
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP
Ankana Daga, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Ahmad Masri, MD, MS
Anjali Owens, MD
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Michael Nassif, MD, MSc
Molecular Precision: How Myosin Inhibitors Redefine Control
When ß-Blockers Fall Short in oHCM: Time for a New Approach?